Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Aplenzin (bupropion hydrobromide) Extended-Release Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011 

Summary View 

 

BOXED WARNING

  • Use in Smoking Cessation Treatment... added

 

5 WARNINGS AND PRECAUTIONS

5.2 Neuropsychiatric Symptoms and Suicide Risk in Smoking Cessation Treatment
  • new section added

 

6 ADVERSE REACTIONS

6.2 Other Events

Nervous System

  • agitation... completed suicide...

 

17 PATIENT COUNSELING INFORMATION

17.1 Counseling Information
  • New section added... Neuropsychiatric Symptoms and Suicide Risk in Smoking Cessation

 

MEDICATION GUIDE

  • multiple and extensive changes. See document for details
-
-